Catalyst Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 6, 2025

Core Viewpoint - Catalyst Pharmaceuticals, Inc. is set to release its second quarter 2025 financial results on August 6, 2025, followed by a conference call and webcast on August 7, 2025, to discuss these results and provide a business update [1][2]. Company Overview - Catalyst Pharmaceuticals is a commercial-stage biopharmaceutical company focused on developing and commercializing novel medicines for patients with rare and difficult-to-treat diseases [1][4]. - The company has a proven track record of bringing life-changing treatments to market and emphasizes patient care and accessibility through a comprehensive suite of support services [4]. - Catalyst is headquartered in Coral Gables, Florida, and has been recognized on the Forbes 2025 list as one of America's Most Successful Mid-Cap Companies and on the 2024 Deloitte Technology Fast 500™ list as one of North America's Fastest-Growing Companies [4]. Conference Call & Webcast Details - The conference call and webcast will take place on August 7, 2025, at 8:30 AM ET [2][3]. - Dial-in numbers for the call include (877) 407-8912 for US/Canada and (201) 689-8059 for international participants [3]. - The webcast will be accessible on the company's website and will be available for replay for at least 30 days following the event [3].